Malignant Pleural Mesothelioma Research

Displaying 1 - 8 of 8CSV
Hwang, Y., Shimamura, Y., Tanaka, J., Miura, A., Sawada, A., Sarmah, H., Shimizu, D., Kondo, Y., Lee, H., Martini, F., Ninish, Z., Yan, K. S., Yamada, K., & Mori, M. (2024). FGF2 promotes the expansion of parietal mesothelial progenitor pools and inhibits BMP4-mediated smooth muscle cell differentiation. Frontiers in Cell and Developmental Biology, 12. https://doi.org/10.3389/fcell.2024.1387237
Publication Date
Yuan, H., Kehm, R. D., Daaboul, J. M., Lloyd, S. E., McDonald, J. A., Mu, L., Tehranifar, P., Zhang, K., Terry, M. B., & Yang, W. (2024). Cancer incidence trends in New York State and associations with common population-level exposures 2010–2018: an ecological study. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-56634-w
Publication Date
Lin, C.-C., Garralda, E., Schöffski, P., Hong, D. S., Siu, L. L., Martin, M., Maur, M., Hui, R., Soo, R. A., Chiu, J., Zhang, T., Ma, B., Kyi, C., Tan, D. S., Cassier, P. A., Sarantopoulos, J., Weickhardt, A., Carvajal, R. D., Spratlin, J., … De Braud, F. (2023). A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies. OncoImmunology, 13(1). https://doi.org/10.1080/2162402x.2023.2290787
Publication Date
Adegunsoye, A., Newton, C. A., Oldham, J. M., Ley, B., Lee, C. T., Linderholm, A. L., Chung, J. H., Garcia, N., Zhang, D., Vij, R., Guzy, R., Jablonski, R., Bag, R., Voogt, R. S., Ma, S.-F., Sperling, A. I., Raghu, G., Martinez, F. J., Strek, M. E., … Noth, I. (2023). Telomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohorts. Nature Communications, 14(1). https://doi.org/10.1038/s41467-023-37193-6
Publication Date
Kim, J. S., Manichaikul, A. W., Hoffman, E. A., Balte, P., Anderson, M. R., Bernstein, E. J., Madahar, P., Oelsner, E. C., Kawut, S. M., Wysoczanski, A., Laine, A. F., Adegunsoye, A., Ma, J. Z., Taub, M. A., Mathias, R. A., Rich, S. S., Rotter, J. I., Noth, I., Garcia, C. K., … Podolanczuk, A. J. (2022). MUC5B, telomere length and longitudinal quantitative interstitial lung changes: the MESA Lung Study. Thorax, 78(6), 566–573. https://doi.org/10.1136/thorax-2021-218139
Publication Date
Ural, B. B., Caron, D. P., Dogra, P., Wells, S. B., Szabo, P. A., Granot, T., Senda, T., Poon, M. M. L., Lam, N., Thapa, P., Lee, Y. S., Kubota, M., Matsumoto, R., & Farber, D. L. (2022). Inhaled particulate accumulation with age impairs immune function and architecture in human lung lymph nodes. Nature Medicine, 28(12), 2622–2632. https://doi.org/10.1038/s41591-022-02073-x
Publication Date
Fang, H.-Y., Stangl, S., Marcazzan, S., Carvalho, M. J. B., Baumeister, T., Anand, A., Strangmann, J., Huspenina, J. S., Wang, T. C., Schmid, R. M., Feith, M., Friess, H., Ntziachristos, V., Multhoff, G., Gorpas, D., & Quante, M. (2021). Targeted Hsp70 fluorescence molecular endoscopy detects dysplasia in Barrett’s esophagus. European Journal of Nuclear Medicine and Molecular Imaging, 49(6), 2049–2063. https://doi.org/10.1007/s00259-021-05582-y
Publication Date
Sahm, V., Maurer, C., Baumeister, T., Anand, A., Strangmann, J., Schmid, R. M., Wang, T. C., & Quante, M. (2022). Telomere shortening accelerates tumor initiation in the L2-IL1B mouse model of Barrett esophagus and emerges as a possible biomarker. Oncotarget, 13(1), 347–359. https://doi.org/10.18632/oncotarget.28198
Publication Date